Drug Profile
Research programme: cancer therapeutics - Kancer
Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Kancer
- Developer Kancer; University of Oklahoma
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Ovarian cancer
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Ovarian-cancer in United Kingdom
- 06 Jul 2016 Early research in Ovarian cancer in United Kingdom (unspecified route)